Supreme Court continues to temporarily maintain mail access to abortion pill
Justice Samuel Alito extended an administrative stay that maintained access to mifepristone through the mail.
Watch CBS News
Justice Samuel Alito extended an administrative stay that maintained access to mifepristone through the mail.
A federal appeals court blocked a FDA rule that allowed the abortion pill mifepristone to be dispensed through the mail.
The Supreme Court preserved nationwide access to medication abortions, but the political debate goes on. Trump said in April he'd release a policy position on the drugs used.
The Supreme Court on Thursday tossed out a challenge targeting the availability of a widely used abortion pill, preserving access to the drug.
The abortion pill legislation could be a template for other states to take aim at the medication commonly used in early-stage pregnancies.
New research shows that more than six in 10 of the abortions in the U.S. last year were done through medication, up from 53% in 2020.
In January, the FDA changed regulations to allow retail pharmacies to sell the drug mifepristone.
The decision from the Supreme Court blocks lower court orders that would have restricted the availability of the abortion pill mifepristone nationwide.
Minnesota's senior senator is weighing in on the debate over mifepristone, a key abortion medication.
Mifepristone is used for about half of abortions in the U.S.
Limits on how late into a pregnancy the drug can be taken, who can prescribe it and how it can be dispensed were set to take effect Saturday at 1 a.m.
Attorney General Merrick Garland said in a statement the Justice Department "strongly disagrees" with the decision from an appeals court.
The court maintained access to mifepristone for the time being but is only letting it be dispensed after a doctor's office visit, not by mail, and up to seven weeks into a pregnancy, not 10.
